30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

PATOU GARY

Insider profile

Performance

Overall performance
2.1

Performance over holding periods
2.1
30 days 90 days 120 days
Average return -9% 8.2% 15.1%
Success rate 18% 68% 82%
Transactions
8 0% Buy
34 71% Buy
47 69% Buy
PATOU GARY's trades of Xenon Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-06-08 2026-06-05 PlS Planned sale
88,478 +20.8%
89.81
US$823,931
88,478 +20.8% 89.81 US$823,931
2026-06-05 2026-06-05 PrS Proposed sale
49,486
227.07
US$515,521
49,486 227.07 US$515,521
2026-06-05 2026-06-05 PrS Proposed sale
60,222
41.74
US$3,848,009
60,222 41.74 US$3,848,009
2024-11-22 2024-11-22 PrS Proposed sale
4,891
41.08
US$200,932
4,891 41.08 US$200,932
2024-11-22 2024-11-22 S Sale
2,040 -8.0%
41.05
US$83,742
2,040 -8.0% 41.05 US$83,742
2024-11-22 2024-11-22 S Sale
2,851 -10.8%
41.11
US$117,205
2,851 -10.8% 41.11 US$117,205
2023-12-14 2023-12-14 PrS Proposed sale
7,598
40.42
US$307,073
7,598 40.42 US$307,073
2023-12-15 2023-12-13 S Sale
7,598 -60.8%
41.05
US$311,898
7,598 -60.8% 41.05 US$311,898
2023-12-15 2023-12-13 S Sale
3,977 -14.4%
39.84
US$158,444
3,977 -14.4% 39.84 US$158,444
2023-12-15 2023-12-13 S Sale
2,303 -8.9%
39.10
US$90,047
2,303 -8.9% 39.10 US$90,047
2023-12-15 2023-12-13 S Sale
5,100 -17.8%
38.94
US$198,594
5,100 -17.8% 38.94 US$198,594
2023-12-13 2023-12-13 PrS Proposed sale
11,380
39.90
US$454,062
11,380 39.90 US$454,062
2022-11-28 2022-11-25 S Sale
1,937 -7.6%
34.79
US$67,390
1,937 -7.6% 34.79 US$67,390
2022-11-28 2022-11-23 S Sale
2,057 -8.0%
34.33
US$70,610
2,057 -8.0% 34.33 US$70,610